Anthera Pharmaceuticals, Inc. ANTH

Full chart Compare
Set alert

Price alert · ANTH

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 4, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00 52-week range 0.001
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $1.65MOther Operating Income → Expenses: $261.00KExpenses → Selling, General & Admin: $11.07MExpenses → Research & Development: $46.51MGross Profit → Expenses: $145.00KRevenue → Gross Profit: $145.00KNet Loss → Expenses: $55.52MOther Income$1.65MOther Operating Income$261.00KGross Profit$145.00KNet Loss$55.52MExpenses$57.58MSelling, General & Admin$11.07MResearch & Development$46.51MRevenue$145.00K

Latest period ending Dec 31, 2017 · select a line to chart its full history

ANTH annual income statement
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
-36.43M-57.18M-35.24M-28.46M-28.25M
-26.87M-55.52M-35.22M-29.60M-30.86M
-2.86-12.87-7.91-10.88-13.52
ANTH annual balance sheet
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
2.20M20.84M46.95M2.64M35.95M
3.67M23.47M48.13M3.49M37.42M
9.17M10.62M8.47M5.75M22.66M
-5.50M12.47M39.66M-2.26M14.76M
ANTH annual cash flow
Fiscal yearFY 2017 Dec 31, 2017FY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013
-36.90M-48.92M-30.91M-25.60M-31.91M
18.25M23.58M75.30M-7.71M43.12M
-18.65M-26.11M44.31M-23.31M6.51M